← Back

Wire · opportunities

FDA Clears 15-Minute Blood Test to Help Distinguish Bacterial From Viral Infections

Published

4 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at patientcareonline.com →

◆ Verified

Fusion42 · 4 November 2026 · Fusion42 review

The FDA has cleared the Access MeMed BV rapid blood test for adults and children to distinguish bacterial from viral infections within 15 minutes, deployable on existing Beckman Coulter immunoassay analyzers. This test aims to reduce antibiotic overuse by providing clinicians with quick immune response data, supporting better treatment decisions in emergency and urgent care settings.

This Wire brief sits within Fusion42's coverage of Medtech, and 7 sources have reported it between 3 Nov 2026 and 4 Nov 2026.

◆ ◆ The Wire takeaway

You can use fast immune response tests on equipment hospitals already have to cut wrong antibiotic use. This opens new routes for emergency care tools that improve how swiftly you decide on infections.

◆ Coverage

7 sources · first reported 3 Nov 2026 · latest 4 Nov 2026

◆ Related on Wire

◆ Topics

Medtechrapid-diagnosticsantibiotic-stewardshipFDA-clearancehospital-careimmune-biomarkers